Results

Q3 results on Feb 02, 2017

| Updated on February 01, 2018 Published on January 17, 2017

Glenmark Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors will be held on February 02, 2017, to consider and approve the Companys Unaudited Financial Statements for the Third Quarter and Nine months ended December 31, 2016 (Q3).

Further, as per the "Code of Conduct for Prevention of Insider Trading" and pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015 the Company has intimated its Directors and other designated persons regarding the closure of trading window from December 26, 2016 to February 06, 2017 (both days inclusive) for the purpose of approval of Unaudited Financial Statements for the Third Quarter and Nine months ended December 31, 2016.

Pdf Link: Q3 results on Feb 02, 2017

Source : BSE - www.bseindia.com

Published on January 17, 2017
This article is closed for comments.
Please Email the Editor